Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Should Moderate FMR Should Be Treated With M-TEER? Experts Duke It Out

News Conference News THT 2026

Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out

Todd Neale

March 06, 2026

Presentation THT 2026

Effect of RV Function on Prognosis in HF and Valvular Heart Disease

Presenter: Kashish Goel

March 04, 2026

Presentation THT 2026

RV Response in Valvular Heart Disease

Presenter: Michael I. Brener

March 04, 2026

Presentation THT 2026

AHF is an Opportunity To Improve CV Care — Arrhythmias, Ischemia, Valvular Heart Disease

Presenter: Marat Fudim

March 02, 2026

Presentation THT 2026

Management of Acute Decompensated Valvular Heart Disease

Presenter: Jörg Hausleiter

March 02, 2026

Presentation THT 2024

Automated Read of Echocardiogram to Identify Cardiomyopathy and Valvular Heart Disease

Presenter: Akhil Narang

March 05, 2024

Presentation THT 2024

Overlap Between Valvular Heart Diseases and HFpEF

Presenter: Yogesh Reddy

March 04, 2024

News Conference News THT 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Caitlin E. Cox

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

Presentation THT 2022

Implications of RVF in Structural Heart Procedures

Presenter: Rebecca Hahn

February 02, 2022

Presentation THT 2022

Novel Medical Therapies for AS

Presenter: Brian Lindman

February 02, 2022

Presentation THT 2022

Moderate AS and HD - TAVR Unload and Beyond

Presenter: Nicolas Van Mieghem

February 02, 2022

Presentation THT 2022

Tricuspid Devices and Studies

Presenter: Susheel Kodali

February 02, 2022

Presentation THT 2022

Percutanous Mitral Valve Repair Devices (Mitral TEER vs Annuloplasty/Chordal Suspension)

Presenter: Mark Reisman

February 02, 2022

Presentation THT 2022

Mitraclip Patient Selection

Presenter: Scott Lim

February 02, 2022

Advertisement

Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out

Effect of RV Function on Prognosis in HF and Valvular Heart Disease

RV Response in Valvular Heart Disease

AHF is an Opportunity To Improve CV Care — Arrhythmias, Ischemia, Valvular Heart Disease

Management of Acute Decompensated Valvular Heart Disease

Automated Read of Echocardiogram to Identify Cardiomyopathy and Valvular Heart Disease

Overlap Between Valvular Heart Diseases and HFpEF

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

TEER or VAD/Transplant in the Advanced HF Patient With MR?

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Implications of RVF in Structural Heart Procedures

Novel Medical Therapies for AS

Moderate AS and HD - TAVR Unload and Beyond

Tricuspid Devices and Studies

Percutanous Mitral Valve Repair Devices (Mitral TEER vs Annuloplasty/Chordal Suspension)

Mitraclip Patient Selection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content